Global & Regional Health Technology Assessment

Current Issue

Vol 8 (2021): In progress

Published: 2021-02-05

Original Research Article

Metastatic renal cancer: real-world evidence from a large Italian claims database

Giulia Ronconi, Letizia Dondi, Carlo Piccinni, Silvia Calabria, Anna Capponcelli, Antonella Pedrini, Maurizio Marangolo, Immacolata Esposito, Carmine Pinto, Nello Martini

1-7
- PDF
- ePub
- html
Continuity of care between hospital pharmacies and community pharmacies, and costs avoided: a pilot experience in times of COVID-19 in Spain

Néboa Zozaya, Almudena González-Domínguez, Natividad Calvente, Rita de la Plaza, Ana Herranz, Antonio Blanes, Miguel Tamayo

8-13
- PDF
- ePub
- html
A comparative analysis of international health technology assessments for novel gene silencing therapies: patisiran and inotersen

Sergio Iannazzo

14-21
- PDF
- ePub
- html
The future of Funds for Innovative Medicines: results from a Delphi Study

Claudio Jommi, Patrizio Armeni, Arianna Bertolani, Francesco Costa, Monica Otto

22-28
- PDF
- ePub
- html
Preparation of intravenous chemotherapy bags: evaluation of a dose banding approach in an Italian oncology hospital

Marco Chiumente, Alberto Russi, Federica Todino, Daniele Mengato, Marina Coppola, Melania Rivano, Angelo Claudio Palozzo, Claudio Jommi

29-34
- PDF
- ePub
- html
Costs of the management of hemophilia A with inhibitors in Spain

Santiago Bonanad, María Teresa Álvarez, Ramiro Núñez, José Luis Poveda, Beatriz Gil, Elena Ruíz-Beato, Ana Durán, Yoana Ivanova, Inés Pérez-Román, Almudena González-Domínguez

35-42
- PDF
- ePub
- html
Cost-effectiveness analysis of caplacizumab in the new standard of care for immune Thrombotic Thrombocytopenic Purpura in Italy

Giovanni Di Minno, Roberto Ravasio

43-52
- PDF
- ePub
- html
Number needed to treat for interleukin inhibitors approved for the treatment of moderate-to-severe plaque psoriasis in Italy

Roberto Ravasio, Antonio Costanzo, Silvia Antonelli, Alessia Maiorino, Serena Losi

53-57
- PDF
- ePub
- html
The Clinical and Economic Benefits of a New Paradigm of HCV Diagnosis and Treatment

Stefano Fagiuoli, Matteo Ruggeri, Filipa Aragao, Rob Blissett

58-66
- PDF
- ePub
- html

Correspondence

View All Issues